BIG PHARMA EARNINGS WATCH: MERCK AND PFIZER
Feb 7, 2025
Pharmaceutical Giants Continue to Outperform Wall Street Projections While… Read More
© 2025 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA EARNINGS WATCH: AMGEN, GSK AND NOVO NORDISK
Feb 7, 2025
Major Pharmaceutical Companies Continue Growing Revenues While Sticking With… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS AND ROCHE
Feb 6, 2025
Big Pharma Giants Report Higher-Than-Expected Q4 Earnings Amid Continued Price… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 30, 2025
Johnson & Johnson Beats Wall Street Analysts’ Expectations Fueled by… Read More
BIG PHARMA WATCH: MERCK EXPEDITES ANTI-COMPETITIVE STRATEGY ON BLOCKBUSTER CANCER DRUG
Jan 27, 2025
Big Pharma Giant’s Patent Abuse Scheme for Keytruda Will Extend Monopoly… Read More
ICYMI: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ANNOUNCES ANNUAL LAUNCH PRICE AND ACCESS REPORT FOR 2025
Jan 22, 2025
New Analysis Will Help Shine a Light on Big Pharma’s Increasingly… Read More
BIG PHARMA WATCH: AARP REPORT FINDS BIG PHARMA HIKES PRICES ON TOP-SELLING BLOCKBUSTERS IN MEDICARE PART D BY AVERAGE OF 98 PERCENT
Jan 10, 2025
Brand Name Drug Companies Nearly Double Prices on Medications Most Often… Read More
DOSE OF REALITY: BIG PHARMA WELCOMES 2025 WITH PRICE HIKES
Jan 7, 2025
Brand Name Drug Companies Increase Prices By More Than Rate of Inflation in… Read More
CSRxP: DISAPPOINTED CONGRESS DID NOT PASS CORNYN-BLUMENTHAL AND Q1/Q2 REFORMS TO HOLD BIG PHARMA ACCOUNTABLE, INCREASE COMPETITION
Dec 21, 2024
Campaign Will Work with Lawmakers in the New Congress and the New… Read More
DOSE OF REALITY: CONGRESS CAN HOLD BIG PHARMA ACCOUNTABLE FOR GAMING THE SYSTEM TO BLOCK COMPETITION, KEEP DRUG PRICES HIGH
Dec 18, 2024
Lawmakers Should Pass Bipartisan, Market-Based Solutions to Crack Down on… Read More
CSRxP: PASSAGE OF CORNYN-BLUMENTHAL AND Q1/Q2 REFORMS WOULD BE POSITIVE STEPS TOWARD HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE
Dec 17, 2024
Bipartisan, Market-Based Solutions Would Crack Down on Big Pharma’s Patent… Read More
ICYMI: CSRxP ANALYSIS FINDS PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS TEN TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN
Dec 17, 2024
Study Finds Big Pharma’s Price-Gouging and Patent Abuse Playbook Fuels… Read More